ADICET BIO INC (ACET)

Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements.

ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023

ACET stock results show that Adicet Bio met analyst estimates for earnings per share the fourth quarter of 2023.

ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Adicet Bio (NASDAQ:ACET) just reported results for the fourth quarter of 2023.A...

Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress

Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

3 High-Risk Stocks That Could Pay Off in the Millions

With the S&P 500 at record highs, betting on these high-risk stocks that could pay off is a tantalizing prospect at this time.

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

7 Top-Tier Penny Stocks for a Smart Bet

Unlock value in penny stocks amid bullish S&P 500 trends and shifting monetary policies, focusing on businesses with solid drivers

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.

Jones upgrades Adicet to buy, cites upcoming catalysts (NASDAQ:ACET)

Jones Trading has upgraded its rating of Adicet Bio (ACET) to buy, citing “robust” interest in the cell therapy space. Jones said it sees approximately ten upco

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Monday 1/29 Insider Buying Report: ACET, CATX

Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Adicet Bio announces pricing of public offering (NASDAQ:ACET)

Adicet Bio announces the pricing of its public offering, with expected gross proceeds of $85.2M, to close on January 25, 2024.

Adicet Bio, Inc. Announces Pricing of Public Offering

Adicet Bio stock sinks on proposed public offering (NASDAQ:ACET)

Adicet Bio starts underwritten public offering, causing its stock to plummet by 15.3%.

Adicet Bio, Inc. Announces Proposed Public Offering

Commit To Purchase Adicet Bio At $2.50, Earn 57.6% Annualized Using Options

Adicet Bio stock rallies 26% on pipeline, cash runway updates (NASDAQ:ACET)

Adicet Bio (ACET) stock rallied 26% after it issued a pipeline update and said it had enough cash to fund operations into the second half of 2025. Read more here.

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024

Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting

Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates